<DOC>
<DOCNO>EP-0657452</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Imidazopyridines.
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K31435	A61K31435	A61K31445	A61K31445	A61K3147	A61K3147	A61K31495	A61K31495	A61P900	A61P900	A61P912	A61P2700	A61P2702	A61P4300	A61P4300	C07D47100	C07D47104	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61P	A61P	A61P	A61P	A61P	A61P	A61P	C07D	C07D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61P9	A61P9	A61P9	A61P27	A61P27	A61P43	A61P43	C07D471	C07D471	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
Imidazopyridine derivatives of the formula I 
<
IMAGE
>
  in which R is 
<
IMAGE
>
 and R
<
1
>
, R
<
2
>
, R
<
3
>
, R
<
4
>
, Ar
<
1
>
, X and Y have the meanings stated in Claim 1, and the salts thereof show angiotensin II-antagonistic properties and can be used for the treatment of hypertension, aldosteronism, heart failure and elevated intraocular pressure and of central nervous system disorders.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
MERCK PATENT GMBH
</APPLICANT-NAME>
<APPLICANT-NAME>
MERCK PATENT GMBH
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
BEIER NORBERT DR
</INVENTOR-NAME>
<INVENTOR-NAME>
DORSCH DIETER DR
</INVENTOR-NAME>
<INVENTOR-NAME>
LUES INGEBORG DR
</INVENTOR-NAME>
<INVENTOR-NAME>
MEDERSKI WERNER DR
</INVENTOR-NAME>
<INVENTOR-NAME>
MINCK KLAUS-OTTO DR
</INVENTOR-NAME>
<INVENTOR-NAME>
OSSWALD MATHIAS DR
</INVENTOR-NAME>
<INVENTOR-NAME>
SCHELLING PIERRE PROF DR
</INVENTOR-NAME>
<INVENTOR-NAME>
BEIER, NORBERT, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
DORSCH, DIETER, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
LUES, INGEBORG, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
MEDERSKI, WERNER, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
MINCK, KLAUS-OTTO, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
OSSWALD, MATHIAS, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
SCHELLING, PIERRE, PROF. DR.
</INVENTOR-NAME>
</INVENTORS>
</TEXT>
</DOC>
